- Home
- GOGL vs ATRC Comparison
GOGL vs ATRC Comparison
Compare GOGL & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOGL
- ATRC
- Stock Information
- Founded
- GOGL N/A
- ATRC 2000
- Country
- GOGL Bermuda
- ATRC United States
- Employees
- GOGL N/A
- ATRC N/A
- Industry
- GOGL Marine Transportation
- ATRC Medical/Dental Instruments
- Sector
- GOGL Consumer Discretionary
- ATRC Health Care
- Exchange
- GOGL Nasdaq
- ATRC Nasdaq
- Market Cap
- GOGL 1.9B
- ATRC 1.5B
- IPO Year
- GOGL 1997
- ATRC 2005
- Fundamental
- Price
- GOGL $7.16
- ATRC $32.01
- Analyst Decision
- GOGL Hold
- ATRC Strong Buy
- Analyst Count
- GOGL 2
- ATRC 10
- Target Price
- GOGL $11.25
- ATRC $48.50
- AVG Volume (30 Days)
- GOGL 5.2M
- ATRC 556.9K
- Earning Date
- GOGL 05-21-2025
- ATRC 04-29-2025
- Dividend Yield
- GOGL 14.94%
- ATRC N/A
- EPS Growth
- GOGL 99.39
- ATRC N/A
- EPS
- GOGL 1.12
- ATRC N/A
- Revenue
- GOGL $968,420,000.00
- ATRC $465,307,000.00
- Revenue This Year
- GOGL N/A
- ATRC $14.60
- Revenue Next Year
- GOGL $16.40
- ATRC $12.58
- P/E Ratio
- GOGL $6.41
- ATRC N/A
- Revenue Growth
- GOGL 9.33
- ATRC 16.55
- 52 Week Low
- GOGL $6.27
- ATRC $18.94
- 52 Week High
- GOGL $15.77
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- GOGL 44.01
- ATRC 43.87
- Support Level
- GOGL $6.94
- ATRC $29.48
- Resistance Level
- GOGL $7.49
- ATRC $33.56
- Average True Range (ATR)
- GOGL 0.41
- ATRC 2.13
- MACD
- GOGL 0.01
- ATRC 0.14
- Stochastic Oscillator
- GOGL 41.78
- ATRC 52.38
About GOGL Golden Ocean Group Limited
Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.